Price T Rowe Associates Inc Cv Rx, Inc. Transaction History

Price T Rowe Associates Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$4.7 - $7.22 $66,613 - $102,329	14,173 Added 2.34%	618,649 $3.72 Million
Q1 2022 May 16, 2022	SELL	$5.62 - $12.37 $11,419 - $25,135	-2,032 Reduced 0.34%	604,476 $3.62 Million
Q4 2021 Feb 14, 2022	SELL	$10.65 - $18.61 $171,539 - $299,751	-16,107 Reduced 2.59%	606,508 $7.42 Million
Q3 2021 Nov 15, 2021	BUY	$14.65 - $26.07 $331,309 - $589,573	22,615 Added 3.77%	622,615 $10.3 Million
Q2 2021 Aug 16, 2021	BUY	$28.0 - $28.0 $16.8 Million - $16.8 Million	600,000 New	600,000 $16.8 Million

14.4M

56.3K

41.8K

Ticker CVRX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 20,576,200
Market Cap $355M
Description
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.